← Leaderboards
Kathleen E Malone
Fred Hutchinson Cancer Center
$13,538,425
Attributed
$20,509,861
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2005–24$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$20,509,861 · 9
By mechanism
R01$19,589,191 · 5
R03$516,233 · 3
P30$404,437 · 1
Top collaborators
- Jonine Lisa Bernstein9 shared
- Christopher I Li5 shared
- Julia A Knight3 shared
Most similar at Fred Hutchinson Cancer Center
Same institution · by research overlap
- A. McGarry Houghton$19,684,845
- Paul D Lampe$17,368,376
- Eric Jessen Chow$11,476,004
Others in their field
Top investigators on “Resources”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$688,986,350
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Eric S Lander · Whitehead Institute For Biomedical Res$341,717,134
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$311,514,701
Research focus
ResourcesMedical RecordsWomanIncidencePopulation BasedMalignant Breast NeoplasmAffectCohortCancer RiskLife StylePharmaceutical PreparationsSecond Primary CancersInterviewGeneral PopulationCancer ControlEpidemiologyRadiationDiagnosisPrognosisHigh RiskPathologyCharacteristicsBreastMalignant Neoplasms
Grant awards (34)
Research Program: Cancer Epidemiology, Prevention & Control$81,930
P30 · FY2024 · CA · contact PI
Research Program: Cancer Epidemiology, Prevention & Control$81,932
P30 · FY2023 · CA · contact PI
Molecular pathoepidemiology of contralateral breast cancer$1,297,113
R01 · FY2022 · CA · contact PI
Research Program: Cancer Epidemiology, Prevention & Control$81,932
P30 · FY2022 · CA · contact PI
Research Program: Cancer Epidemiology, Prevention & Control$77,210
P30 · FY2021 · CA · contact PI
Molecular pathoepidemiology of contralateral breast cancer$1
R01 · FY2021 · CA · contact PI
Molecular pathoepidemiology of contralateral breast cancer$2,016,169
R01 · FY2020 · CA · contact PI
Research Program: Cancer Epidemiology, Prevention & Control$81,433
P30 · FY2020 · CA · contact PI
Molecular pathoepidemiology of contralateral breast cancer$414,309
R01 · FY2019 · CA · contact PI
Molecular pathoepidemiology of contralateral breast cancer$1,850,931
R01 · FY2018 · CA · contact PI
Epidemiology of the four most frequent cancers following breast cancer$928,970
R01 · FY2018 · CA · contact PI
Molecular pathoepidemiology of contralateral breast cancer$1,438,154
R01 · FY2017 · CA · contact PI
Epidemiology of the four most frequent cancers following breast cancer$956,771
R01 · FY2017 · CA · contact PI
Epidemiology of the four most frequent cancers following breast cancer$935,354
R01 · FY2016 · CA · contact PI
Epidemiology of the four most frequent cancers following breast cancer$952,389
R01 · FY2015 · CA · contact PI
Epidemiology of the four most frequent cancers following breast cancer$932,958
R01 · FY2014 · CA · contact PI
Mammographic Density and Risk of Contralateral Breast Cancer$520,559
R01 · FY2014 · CA
Tamoxifen, P450 and UGT Enzyme Genetic Variation, and Breast Cancer Recurrence/Mo$85,360
R03 · FY2014 · CA · contact PI
Mammographic Density and Risk of Contralateral Breast Cancer$546,559
R01 · FY2013 · CA
Tamoxifen, P450 and UGT Enzyme Genetic Variation, and Breast Cancer Recurrence/Mo$88,000
R03 · FY2013 · CA · contact PI
Mammographic Density and Risk of Contralateral Breast Cancer$597,697
R01 · FY2012 · CA
Breast cancer prognostic factors/pathobiology$174,409
R01 · FY2009 · CA · contact PI
Breast cancer prognostic factors/pathobiology$797,054
R01 · FY2008 · CA · contact PI
Breast cancer prognostic factors/pathobiology$1,125,376
R01 · FY2007 · CA · contact PI
Breast cancer prognostic factors/pathobiology$1,147,506
R01 · FY2006 · CA · contact PI
Breast cancer and HRT: genetic susceptibility within th*$84,467
R03 · FY2006 · CA · contact PI
Breast cancer prognostic factors/pathobiology$1,038,254
R01 · FY2005 · CA
Breast cancer and HRT: genetic susceptibility within th*$86,500
R03 · FY2005 · CA
Breast cancer prognostic factors/pathobiology$874,600
R01 · FY2004 · CA
FACTORS AFFECTING SURVIVAL OF YOUNG CANCER PATIENTS$331,944
R01 · FY2002 · CA
Adiposity Related Biomarkers and Breast Tumor Size$85,422
R03 · FY2002 · CA
FACTORS AFFECTING SURVIVAL OF YOUNG CANCER PATIENTS$370,071
R01 · FY2001 · CA
Adiposity Related Biomarkers and Breast Tumor Size$86,484
R03 · FY2001 · CA
FACTORS AFFECTING SURVIVAL OF YOUNG CANCER PATIENTS$342,043
R01 · FY2000 · CA